Simon F. Campbell

ICC, Route De Pré Bois 20
Geneve, GE 1215, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Optimization of Species-Selective Reversible Proteasome Inhibitors for the Treatment of Malaria.

Optimization of Species-Selective Reversible Proteasome Inhibitors for the Treatment of Malaria.

Journal: Journal of medicinal chemistry

Published: October 28, 2025

Identification of potent and reversible piperidine carboxamides that are species-selective orally active proteasome inhibitors to treat malaria.

Identification of potent and reversible piperidine carboxamides that are species-selective orally active proteasome inhibitors to treat malaria.

Journal: Cell chemical biology

Published: March 04, 2024

Hit-to-lead optimization of a 2-aminobenzimidazole series as new candidates for chagas disease.

Hit-to-lead optimization of a 2-aminobenzimidazole series as new candidates for chagas disease.

Journal: European journal of medicinal chemistry

Published: September 25, 2022

Discovery and Preclinical Pharmacology of INE963, a Potent and Fast-Acting Blood-Stage Antimalarial with a High Barrier to Resistance and Potential for Single-Dose Cures in Uncomplicated Malaria.

Discovery and Preclinical Pharmacology of INE963, a Potent and Fast-Acting Blood-Stage Antimalarial with a High Barrier to Resistance and Potential for Single-Dose Cures in Uncomplicated Malaria.

Journal: Journal of medicinal chemistry

Published: March 01, 2022

Hit-to-lead optimization of a benzene sulfonamide series for potential antileishmanial agents.

Hit-to-lead optimization of a benzene sulfonamide series for potential antileishmanial agents.

Journal: RSC medicinal chemistry

Published: June 04, 2021

The antimalarial MMV688533 provides potential for single-dose cures with a high barrier to Plasmodium falciparum parasite resistance.

The antimalarial MMV688533 provides potential for single-dose cures with a high barrier to Plasmodium falciparum parasite resistance.

Journal: Science translational medicine

Published: January 15, 2021

2-aminobenzimidazoles for leishmaniasis: From initial hit discovery to in vivo profiling.

2-aminobenzimidazoles for leishmaniasis: From initial hit discovery to in vivo profiling.

Journal: PLoS neglected tropical diseases

Published: September 10, 2020

Substituted Aminoacetamides as Novel Leads for Malaria Treatment.

Substituted Aminoacetamides as Novel Leads for Malaria Treatment.

Journal: ChemMedChem

Published: June 01, 2019

2,3,8-Trisubstituted Quinolines with Antimalarial Activity.

2,3,8-Trisubstituted Quinolines with Antimalarial Activity.

Journal: Anais da Academia Brasileira de Ciencias

Published: October 13, 2017

Novel inhibitors of Plasmodium falciparum based on 2,5-disubstituted furans.

Novel inhibitors of Plasmodium falciparum based on 2,5-disubstituted furans.

Journal: European journal of medicinal chemistry

Published: October 31, 2016

Discovery of a Quinoline-4-carboxamide Derivative with a Novel Mechanism of Action, Multistage Antimalarial Activity, and Potent in Vivo Efficacy.

Discovery of a Quinoline-4-carboxamide Derivative with a Novel Mechanism of Action, Multistage Antimalarial Activity, and Potent in Vivo Efficacy.

Journal: Journal of medicinal chemistry

Published: September 16, 2016

A tetraoxane-based antimalarial drug candidate that overcomes PfK13-C580Y dependent artemisinin resistance.

A tetraoxane-based antimalarial drug candidate that overcomes PfK13-C580Y dependent artemisinin resistance.

Journal: Nature communications

Published: September 02, 2016

Showing 1-12 of 15

Last Updated: 09/26/2026